SJS Investment Consulting »

Aldeyra Therapeutics shares owned by SJS Investment Consulting

Quarter-by-quarter ownership of Aldeyra Therapeutics (ALDX) shares owned by SJS Investment Consulting from 13F filings

Historical chart of SJS Investment Consulting investment in Aldeyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aldeyra Therapeutics held by SJS Investment Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aldeyra Therapeutics by SJS Investment Consulting

Quarter filed Position value Share count Share price at filing
2025-12-31 $73 14 5.21

More positions owned by SJS Investment Consulting

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Ultrashort Fixed (DUSB)
Vanguard Malvern Fds Core Bd Etf (VCRB)
Dimensional Etf Trust Short Duration F (DFSD)
Eli Lilly & Co. (LLY)
Apple (AAPL)
Vanguard Malvern Fds Strm Infproidx (VTIP)
American Centy Etf Tr Avantis Emgmkt (AVEM)
American Centy Etf Tr Us Eqt Etf (AVUS)
Hormel Foods Corporation (HRL)
Dimensional Etf Trust Us Sustainabilty (DFSU)
Vanguard Instl Index 0-3 Mo Treas Bil (VBIL)
Dimensional Etf Trust World Ex Us Core (DFAX)
NVIDIA Corporation (NVDA)

View all positions for SJS Investment Consulting

Top funds holding Aldeyra Therapeutics

Knoll Capital Management
Perceptive Advisors
BlackRock
Vanguard Group
Ardsley Advisory Partners
683 Capital Management
AQR Capital Management
D. E. Shaw & Co
Kingdon Capital Management
Kennedy Capital Management
Geode Capital Management
State Street Corporation
Acadian Asset Management
Jacobs Levy Equity Management
Dimensional Fund Advisors

View all funds holding Aldeyra Therapeutics